QA: Savara Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001160308_2013_Savara_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'0120 - Statement - Consolidated Statements of Operations and Comprehensive Income/(Loss)': 24, '0121 - Statement - Consolidated Statements of Operations and Comprehensive Income/(Loss) (Alternative)': 3}}

Graph

Absolute values for 0001160308, Savara Inc

  xvar xval
0 AssetsCurrent 37,173,662
1 IntangibleAssetsNetIncludingGoodwill 3,006,883
2 PropertyPlantAndEquipmentNet 198,358
3 remainder_Assets 6,592,912
4 LiabilitiesCurrent 2,570,666
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,608,755
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 67,666,712
9 ResearchAndDevelopmentExpense 86,057,456
10 remainder_Expenses 28,242,906
11 remainder_Revenues 2,093,522
12 remainder_NetIncome -7,277,775
13 remainder_ComprehensiveNetIncome -28,015
  yvar yval
0 Assets 46,971,815
1 Liabilities 5,179,421
2 Expenses 181,967,074
3 Revenues 2,093,522
4 StockholdersEquity 41,792,394
5 NetIncome -187,151,327
6 ComprehensiveNetIncome -187,165,334
7 BaseVar 121,758,811
8 EconomicCapitalRatiobeforeLimitedLiability -3.68
9 EconomicCapitalRatio 0.476

Edgar->Model Mapping

Feature Distribution

Change over Time